/Bio-Techne%20Corp%20logo%20and%20data-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions dedicated to advancing biomedical research and diagnostics. With a market cap of $10.4 billion, Bio-Techne develops innovative reagents, instruments, and diagnostic tools that support healthcare providers, laboratories, and researchers in the life sciences industry.
Shares of Bio-Techne have underperformed the broader market over the past year. The stock has declined 6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 22.3%. In 2025, the stock is down 8.5%, while SPX has gained 4% on a YTD basis.